How do U.S. drugs come to cost more? Let us count the ways

Tracy Staton Why the disparity in drug prices? It's a question asked repeatedly, and the specific answers are multifarious and complex.  FiercePharma News

Sanofi plots more cuts at slow-footed French R&D shop

Damian Garde Long bedeviled by union protests and government chidings, Sanofi is again planning to pare down its French R&D operation, plotting 186 job cuts as worker groups mobilize ...

Vivus nabs more marketing muscle for Stendra, but nothing yet for Qsymia

Carly Helfand Vivus investors are still waiting for the company to nail down the marketing partner the company's leadership promised would help turn things around for weight-loss ...

Teva plots 5,000 more job cuts in $2B savings drive

Tracy Staton Teva Pharmaceutical Industries is already in the middle of a big cost-cutting push. And it's about to get bigger. The Israel-based generics giant plans to lay off up ...

Study: More Than Half Now Write “e-prescriptions”

barbara.lempert AJMC Study: More Than Half Now Write “e-prescriptions” Changes to federal law encouraging the use of e-prescriptions may have helped cause a jump in their use from ...

Novartis, Biogen Idec release more strong data on hot-selling MS pills

Carly Helfand The day after showing that two of their respective therapies provided better results with earlier treatments, the companies followed up with analyses of safety and brain ...

Merck KGaA Shares More Management Changes

mia.burns Merck KGaA Announces Further Management Changes to Drive Pharmaceutical Business Growth •Stefan Oschmann to focus on role as Head of Pharmaceuticals in charge of the biopharmaceutical ...

Americans Want More Oversight Of Compound Pharmacies: Survey

esilverman As the House and Senate get set to reconcile legislation for giving the FDA more authority over compounding pharmacies, a new survey conducted by a coalition that ...

Malaria No More and Novartis launch Power of One

barbara.lempert Malaria No More and Novartis launch Power of One, a global digital fundraising campaign to help eliminate malaria deaths •    Power of One enables the ...

Researchers: UK needs more AMR funding

mia.burns By Mia Burns (mia.burns@ubm.com) Despite the severe threat that the emergence of antimicrobial resistance poses to the ability to treat many infections, the United Kingdom ...

Pharma M&A volume is up, thanks to Amgen. More to come?

Tracy Staton Amgen's agreement to buy Onyx Pharmaceuticals made the biggest headlines in pharma this week. It also pushed the industry's M&A stats into bragging territory. ...

Saline that starts at $1.07 ends up costing about 90 times more

Eric Palmer The New York Times recently found out that different patients treated in a recent food-poisoning event paid prices that ranged over hundreds of dollars for basic IV saline ...
Page 4 of 8« First...23456...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS